405 The lockdown effect on gynaecological cancer surgeries during the COVID-19 Pandemic

por Theodoulidis, V., Vlachos, D., Theofanakis, C., Pergialiotis, V., Thomakos, N., Rodolakis, A., Haidopoulos, D.
Publicado 2022

Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy

por Liontos, M., Andrikopoulou, A., Koutsoukos, K., Markellos, C., Skafida, E., Fiste, O., Kaparelou, M., Thomakos, N., Haidopoulos, D., Rodolakis, A., Dimopoulos, M. A., Zagouri, F.
Publicado 2021

VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2

por Gavalas, N G, Tsiatas, M, Tsitsilonis, O, Politi, E, Ioannou, K, Ziogas, A C, Rodolakis, A, Vlahos, G, Thomakos, N, Haidopoulos, D, Terpos, E, Antsaklis, A, Dimopoulos, M A, Bamias, A
Publicado 2012

77P The impact of COVID-19 on gynecological cancer diagnoses in Greece

por Fiste, O., Iliopoulou, P., Tzannis, K., Theofanakis, C., Rouvali, A., Markellos, C., Kunadis, E., Potiri, E., Papanota, A-M., Papatheodoridi, A., Andrikopoulou, A., Svarna, A., Kaparelou, M., Koutsoukos, K., Thomakos, N., Haidopoulos, D., Rodolakis, A., Zagouri, F., Dimopoulos, M., Liontos, M.
Publicado 2023